Tatva Chintan Pharma Chem Limited (TATVA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.61B |
| Enterprise Value | 25.73B |
| P/E Ratio | 63.54 |
| PEG Ratio | 0.25 |
| Price/Sales Ratio | 6.15 |
| Price/Book Ratio | 4.91 |
| Enterprise/Revenue | 6.39 |
| Enterprise/EBITDA | 32.08 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 5.06B |
| Revenue/Share | 277.81 |
| Gross Profit | 1.82B |
| EBITDA | 967.07M |
| Net Income | 420.54M |
| Diluted EPS | 17.98 |
Balance Sheet
| Total Cash | 152.05M |
| Total Cash/Share | 6.5 |
| Total Debt | 1.7B |
| Total Debt/Equity | 0.21 |
| Current Ratio | 1.59 |
| Book Value Per Share | 348.26 |
Price History
| 52-Week Change | 24.17 |
| 52-Week High | 2,113.6 |
| 52-Week Low | 1,044.1 |
| Moving Average 50 Days | 1,733.01 |
| Moving Average 200 Days | 1,393.72 |
Statistics
| Average Volume | 100,726 |
| Shares Outstanding | 23.39M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 0.12 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
